More Neuren Pharmaceuticals Limited news
Neuren Pharmaceuticals LimitedASX: NEU

S&P DJ Indices Announces March Quarterly Rebalance

Mar 8, 2018 at 9:49 PM EST · Issued by Neuren Pharmaceuticals Limited

Filed with ASX · Mar 8, 2018 at 9:49 PM EST · 8 pages · English

On 6ix: 6ix.com/news/sandp-dj-indices-announces-march-quarterly-rebalance-48

Neuren Pharmaceuticals Limited on 6ix

Earlier from Neuren Pharmaceuticals

  • Preliminary Final ReportFeb 28, 2018
  • Neuren announces new US patent to be granted for NNZ-2591Dec 5, 2017
  • Consolidation/Split - NEUNov 16, 2017
  • Neuren FDA meeting confirms Phase 3 plan for Rett syndromeOct 12, 2017
  • Presentations and publication for Rett syndrome trialsOct 4, 2017

Later from Neuren Pharmaceuticals

  • Disclosure under Listing Rule 4.3DMar 29, 2018
  • First patent in Japan granted for Neurens trofinetideApr 29, 2018
  • Neuren announces investment and exclusive negotiation periodMay 20, 2018
  • Announcement of buy-back - Appendix 3CMay 30, 2018
  • Neuren and ACADIA announce agreement for North AmericaAug 6, 2018
All Neuren Pharmaceuticals news releases↗

Follow Neuren Pharmaceuticals into a list and get an email when it puts out news.

Follow Neuren Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer